Published in Gene Therapy Weekly, March 20th, 1995
This trial is being conducted in parallel with another GTI-sponsored Phase I/II clinical trial for operable malignant brain tumors currently ongoing at three trial sites.
In this study, an initial 15 patients will be enrolled. The protocol involves a direct injection into the tumor of cells that produce genetically altered vectors, which transfer into tumor cells the gene for the enzyme...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.